Tianqi Sun

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Signal transduction and targeted therapy

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yanni Wang, Chang Liu, Huan Chen, Xi Jiao, Yujiao Wang, Yanshuo Cao, Jian Li, Xiaotian Zhang, Yu Sun, Na Zhuo, Fengxiao Dong, Mengting Gao, Fengyuan Wang, Liyuan Dong, Jifang Gong, Tianqi Sun, Wei Zhu, Henghui Zhang, Lin Shen, Zhihao Lu
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Yanni Wang, Chang Liu, Huan Chen, Xi Jiao, Yujiao Wang, Yanshuo Cao, Jian Li, Xiaotian Zhang, Yu Sun, Na Zhuo, Fengxiao Dong, Mengting Gao, Fengyuan Wang, Liyuan Dong, Jifang Gong, Tianqi Sun, Wei Zhu, Henghui Zhang, Lin Shen, Zhihao Lu
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Yanni Wang, Chang Liu, Huan Chen, Xi Jiao, Yujiao Wang, Yanshuo Cao, Jian Li, Xiaotian Zhang, Yu Sun, Na Zhuo, Fengxiao Dong, Mengting Gao, Fengyuan Wang, Liyuan Dong, Jifang Gong, Tianqi Sun, Wei Zhu, Henghui Zhang, Lin Shen, Zhihao Lu
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Lei Li, Yu Gu, Mengpei Zhang, Xiaohua Shi, Zhe Li, Xinyun Xu, Tianqi Sun, Yu Dong, Chao Xue, Xiaoru Zhu, Ran Lv, Kai Jiao, Xuwo Ji, Li-Juan Wang, Yang Zhang, Zhiyong Liang, Ying Jin, Rutie Yin, Ming Wu, Han Liang
HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients. NPJ precision oncology 7 (1) (2023)